Aumann AG (0RO8)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 13.03 |
|---|---|
| 52-week range | 11.30 – 16.20 |
| Return, 1 month / 3 months | −2.6% / +3.0% |
| Return, 1 year / 3 years | +12.1% / +13.4% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -19.2% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 5.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aumann AG is a German engineering company that builds automated production equipment and machinery for manufacturers. Its main work covers winding technology for electric motors and assembly lines for automotive and industrial customers, along with other automation and handling systems. The company is based in Beelen, Germany, and supplies equipment to manufacturers in Europe and other markets. Its machines help customers produce components and assemblies with a high degree of automation.
The shares are listed on the London Exchange in UK under the code 0RO8, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aumann AG (0RO8) trades on the London Exchange in UK. It last closed at EUR 13.03 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,814 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.1% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.3% | ||
| From 52-week high | -16.6% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | 1.1% | ||
| 12-month return, skipping the last month | 15.1% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.2% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.0% |
|---|---|
| 1 month | −2.6% |
| 3 months | +3.0% |
| 6 months | +1.1% |
| 1 year | +12.1% |
| 3 years | +13.4% |
| 5 years | −15.9% |
Signals
| 50-day / 200-day average | 13.67 / 13.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | EUR 0.7400 |
| 16 Jun 2025 | EUR 0.1700 |
| 19 Jun 2024 | EUR 0.2000 |
| 16 Jun 2023 | EUR 0.1000 |
| 9 Jun 2022 | EUR 0.1000 |
| 7 Jun 2019 | EUR 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.